Here are the latest notable updates on glyphosate:
A high-profile 2026 development involves re-evaluation of glyphosate safety in the United States. A January 2026 investigative report highlighted controversy over a long-standing study and renewed calls for EPA reassessment of glyphosate’s cancer risk, though the EPA has emphasized that its current stance is based on a broader evidence base beyond the retracted study. This development has kept glyphosate in the public and policy spotlight.[1]
In early 2026, industry and advocacy groups continued to push contrasting narratives about glyphosate’s safety. Reports indicate ongoing litigation pressure and political debates around potential regulatory changes, with some groups urging stricter reviews or restrictions and others defending current registration and usage guidelines.[1]
Coverage from trade and activist outlets in 2025–early 2026 notes continued scrutiny of risk assessments and regulatory decisions, including concerns raised about data transparency and reliance on certain studies. They also mention Supreme Court considerations and potential legal protections affecting Bayer’s exposure to glyphosate-related lawsuits.[2][3]
Sector-specific outlets and health news aggregators continued to report on research into glyphosate’s health and environmental effects, including discussions about co-exposures with other pesticides and gaps in ecological risk assessments. These sources emphasize that scientific and regulatory conclusions remain nuanced and context-dependent, with multiple agencies re-evaluating different aspects of glyphosate risk.[3][8]
Canadian context: Canadian media highlighted the 2025 retraction of a key glyphosate safety paper that sparked calls for health authority reviews, though Health Canada indicated it would reassess primary data sources and maintain independent review processes. This underscores ongoing international attention to glyphosate safety and regulatory responses.[4]
If you’d like, I can pull a concise, current snapshot from a few reputable outlets and provide direct links with brief summaries tailored to your region (Montréal, QC) and any specific aspects you care about (cancer risk, environmental impact, or regulatory actions). I can also set up a quick alert checklist for ongoing glyphosate developments.
This Review leads with the disturbing news that the director of the Ramazzini Institute, which led the recent Global Glyphosate Study, has been fired, with no reason given (CORPORATE CAPTURE). We cover developments regarding Bayer’s desperate attempts to get legal immunity agains
gmwatch.orgDaily science news on research developments, technological breakthroughs and the latest scientific innovations
phys.orgLatest London news, business, sport, showbiz and entertainment from the London Evening Standard.
www.standard.co.ukScientists say that more research is needed on the impact of the weedkiller, with a new study showing traces in kids
www.cbsnews.comThe journal Regulatory Toxicology and Pharmacology retracted the paper last week, citing documents made public through litigation in the U.S. The retraction notice cited documents made public through litigation in the U.S. that suggest employees of Monsanto, which makes Roundup, may have helped write the article without proper acknowledgment — a practice known as ghostwriting. The retraction notice said the conclusions on whether glyphosate causes cancer were "solely based on unpublished...
www.cbc.caGlyphosate is the most widely – and the most heavily – used pesticide in the world, including on at least 80% of all GM crops. This scale of use, which is likely to skyrocket still further given the current drive to deregulate GMOs, is leading to widespread hu
gmwatch.orgMedical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and conditions, medications and more.
medicalxpress.comProblems with a 25-year-old landmark paper on the safety of Roundup's active ingredient, glyphosate, have led to calls for the E.P.A. to reassess the widely used chemical.
www.nytimes.comIn this edition: Bayer Responds to New Glyphosate Study: ‘It is clear this study has serious Methodological Flaws’ Water Hardness Check Key to Glyphosate Efficacy Trump-backed Pesticide Report Led by RFK Jr. Draws Fire from Agrichemical Industry Bayer Settles Missouri Roundup Case Mid-trial; Looks to U.S. Supreme Court Are We Really Losing Roundup?
www.no-tillfarmer.com